ventilation-care@home - developing an innovative concept of care for people using long-term mechanical ventilatio
- Conditions
- patients within the weaning category prolonged weaning group 3c (weaning failure) orpatients after an elective initiation of invasive home mechanical ventilation (HMV)J96.11J96.10Z99.1Dependence on respirator
- Registration Number
- DRKS00009524
- Lead Sponsor
- Charité Universitätsmedizin Berlin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
• invasive home mechanical ventilation
• male or female adults (=18 years when admited to Charité university hospital (CharitéCenter 12 or 07)
• transfer to the REMEO-Center (Berlin) after the patient has given an informed consent
• patients unable to give consent
• lack of understanding the German language
• court-ordered civil committment to an approved institution
• staff of the Charité university hospital
• declined informed consent that pseudonymised data may be stored and relayed within the scope of this clinical study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method proof of principle of an intersectoral care concept with the following outcome:<br>1. Improvement of intersectoral (outpatient and clinical) communication and collaboration, especially concerning the multiprofessional care-team (physicians, nurses, therapists)<br>2. Optimizing the data for outcome, quality of life readmission rate etc. by incorporating the experiences and views of patients (interviews).<br>3. Evaluation of guideline-based processes in home mechanical ventilation by developing and measuring key performance indicators and quality indicators and thereby<br>4. development of evidence in regard to the care situation of patients on long-term home mechanical ventilation<br>5. Optimizing the use of resources (gentle use of limited resources in light of the demographic change, lack of nurses and physicians and financial resources) by early identification of weaning potential and prevention of readmission<br>6. Cost savings by preventing revolving dorr effect”
- Secondary Outcome Measures
Name Time Method 7. Improvement of self-determination and patient autonomy of the chronically critically ill by facilitating communication to care-givers and family members<br>8. Empowerment of family members and patients; strengthening of the sense of security; electronic delivery of accessible training material of Linde REMEO for patients, nurses and family members which can be viewed on tjhe PAUL-Tablet in PDF-format.